Long COVID-19 study identifies novel blood markers as potential diagnostic and therapeutic targets
Antisense Therapeutics Limited World first study utilizing Somalogic SomaScan® assay# to assess up to 7,000 plasma proteins in Long COVID-19 patients has elucidated novel blood markers as potential ...